Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
54.93 Up 1.76(3.31%) Jul 31, 4:00PM EDT
|After Hours : 54.45 Down 0.48 (0.87%) Jul 31, 6:09PM EDT
Add to Portfolio
Prev Close:53.17
Open:53.53
Bid:N/A
Ask:55.13 x 200
1y Target Est:68.78
Beta:2.27
Next Earnings Date: 4-Aug-15ISIS Earnings announcement
Day's Range:52.80 - 55.56
52wk Range:29.17 - 77.80
Volume:1,589,220
Avg Vol (3m):2,328,350
Market Cap:6.58B
P/E (ttm):N/A
EPS (ttm):-0.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ISISUp 3.31%6.58B
ENZDown 0.66%138.18M
GILDDown 0.03%173.21B
SRPTUp 0.50%1.32B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):25.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.32
Quarterly EPS Est (Jun-15) :0.29
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-7.21

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback